Order Article Reprints

Johnson LM, Krovi SA, Li L, Girouard N, Demkovich ZR, Myers D, Creelman B, van der Straten A. Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP). Pharmaceutics. 2019; 11(7):315. https://doi.org/10.3390/pharmaceutics11070315

Johnson, Leah M., Sai Archana Krovi, Linying Li, Natalie Girouard, Zach R. Demkovich, Daniel Myers, Ben Creelman, and Ariane van der Straten. 2019. "Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP)" Pharmaceutics 11, no. 7: 315. https://doi.org/10.3390/pharmaceutics11070315

Johnson, L. M., Krovi, S. A., Li, L., Girouard, N., Demkovich, Z. R., Myers, D., Creelman, B., & van der Straten, A. (2019). Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP). Pharmaceutics, 11(7), 315. https://doi.org/10.3390/pharmaceutics11070315